Abstract
Background
Immune thrombocytopenia (ITP) is an immune-mediated platelet disorder in which autoantibody-coated platelets are removed from the blood by monocytic phagocytes and there is impaired platelet production. There is a delicate balance of specific cytokine levels, which has an important role in the immune system and is known to be deregulated in autoimmune diseases. This study was designed to investigate the differences in Th cytokine levels between children and adults with newly diagnosed ITP and to compare these profiles to those found in healthy, age-matched controls.
Material/Methods
The concentration of IL-1α, IL-2, IL-3, IL-4, IL-6, IL-10, TNF-α, IFN-α, and IFN-γ in serum specimens was analyzed by enzyme-linked immunosorbent assay.
Results
At the time of ITP diagnosis, children showed significantly lower serum levels of interleukin IL-2 and tumor necrosis factor TNF-α and higher serum level of IL-3 than healthy controls. Serum level of IL-4 in adult ITP patients was higher than those in control subjects. When compared with adults, children with ITP had lower serum level of IL-4, IL-6 and IFN-γ, and higher level of IFN-α.
Conclusions
Significant differences in serum cytokine levels between pediatric patients and healthy controls indicate that cytokine disturbances – especially changes in IL-2, IL-3 and TNF-α – might be involved in the pathogenesis of newly diagnosed ITP. TNF-α is the most informative variable for discrimination between healthy children and those with ITP.
Keywords: immune thrombocytopenia, serum cytokines level, children, adults
Background
Immune thrombocytopenia (ITP) is an immune-mediated platelet disorder in which autoantibody-coated platelets are removed from the blood by monocytic phagocytes, resulting in a remarkable decrease of platelet count, accompanied by impaired platelet production. Based on disease duration, ITP is classified into acute (newly diagnosed), persistent (3–12 months’ duration) and chronic (>12 month duration) [1,2]. Both children and adults are prone to the development of persistent and chronic forms of the disorder, although the majority of childhood cases are acute and resolve successfully without therapy within 6 months [2,3]. Disease in adults is generally chronic (80%) and relapsing, and typically remains refractory to treatment [4].
The cytokine balance regulates the immune system under normal conditions and is impaired in many autoimmune diseases. Several studies support a role for serum cytokines in the pathogenesis of ITP, and provide evidence to suggest that helper T-lymphocytes polarize into Th1 and Th2 immune response [5,6]. Th1 response is characterized primarily by the presence of cytokines IL-2, INF-γ, and TNF-α, whereas Th2 response produces IL-4, IL-5, IL-6, IL-10 and IL-13. However, human Th1 and Th2 subsets are defined according to IFN-γ and IL-4 production because the synthesis of other cytokines is not stringently restricted to a single subset [5,6]. Recent studies of polymorphisms of genes that code for proteins included in proinflammatory immune response suggests that they contribute to the pathogenesis of ITP [7–10]. The ratio of Th1/Th2 to T1/T2 is significantly higher in ITP patients then in healthy controls [11,12]. Some studies have found evidence supporting Th2 polarization, suggesting that the Th1/Th2 ratio is directly correlated with platelet counts [13].
To further investigate the role and imbalance of Th cytokines in the pathogenesis of ITP, we measured serum concentration of IL-1α, IL-2, IL-3, IL-4, IL-6, IL-10, TNF-α, IFN-α, and IFN-γ in newly diagnosed pediatric and adult ITP patients.
Material and Methods
Patients
All participants or their legal representatives provided written informed consent before entry into the study, which was approved by the Ethics Committee of the Clinical Hospital Centre Split, Croatia, where the study was conduct. Forty-five pediatric patients (age range, 8 months to 14 years) and 19 adult patients (age range, 15–86 years), as well as 26 pediatric (age range, 1–12 years) and 24 adult healthy volunteers (age range, 15–50 years) were enrolled in the study. Patients and age-matched controls were Caucasians form south Croatia (Dalmatia). Heparinized venous blood samples were collected from each patient (at presentation time) and control subject. Serum samples were preserved at –80°C in aliquots for cytokine assays and were thawed only once.
Inclusion criteria were: newly diagnosed ITP (no patients were in persistent or chronic phase of disease) with platelet count below 80×109/L, no comorbidity, and no obvious initiating and/or underlying cause of thrombocytopenia
Serum cytokines measurement
Serum levels of IL-1α, IL-2, IL-3, IL-4, IL-6, IL-10, TNF-α, IFN-α, and IFN-γ were determined using the quantitative sandwich enzyme-linked immunosorbent assay (ELISA) (Quantikine Immunoassay, R&D Systems Inc., Minneapolis, MN) [14].
Statistical analysis
Counted data are presented as numbers (N) and percentages (%), and difference between them was analyzed using the chi-squared test. Measured data are presented as medians and inter-quartile range (lower quartile to upper quartile), and were analyzed using the 2-group multivariate permutation test, which is the most appropriate test, considering group sizes and distributions. This test uses a 2-step procedure: (1) the overall P value is calculated, and (2) an individual permutation test for each variable is performed. However, the P values for the individual permutation tests are considered as significant only if overall P value is £0.05. Multivariate data analysis was done using the JRIP classification system in Weka software. The system generates rules that explain difference between groups under investigation. Data analysis was made using R and Weka software [15–17].
Results
Platelet count
At the time of diagnosis, the platelet count was significantly lower in children than in adults (p=0.014). Of the 45 children with ITP, 26 (58%) had a platelet count below 10×109/L, compared with 5/19 (26%) adult patients (Table 1).
Table 1.
Distribution of platelet counts in children and adults with ITP at the time of diagnosis.
| Platelet count | Children, N (%)* | Adults, N (%)* |
|---|---|---|
| No higher than 10×109/L | 26 (58) | 5 (26) |
| 10.1–30.0×109/L | 8 (18) | 3 (16) |
| 30.1–50.0×109/L | 8 (18) | 4 (21) |
| 50.1–80.0×109/L | 3 (6) | 7 (37) |
| Total | 45 (100) | 19 (100) |
N – number of patients;% – percentage of patients (chi-square =10.622, df=3, P=0.0140). The normal range of platelet count: children – 170–420×109/L; adults – 150–400×109/L.
Serum cytokine levels
Differences in serum cytokines level between healthy children and children with newly diagnosed primary ITP are presented in Table 2. Significantly lower levels of IL-2 (p=0.0148) and TNF-α (p=0.0025) and higher level of IL-3 were found in diseased children (p=0.0405). The level of other cytokines was not significantly different between these 2 groups of children (Table 2).
Table 2.
Serum cytokine levels in children with newly diagnosed ITP and in healthy controls.
| Cytokine (pg/mL) | Healthy children* | Children with ITP* | P value** |
|---|---|---|---|
| IL-1α | 2.21 (1.20 to 3.90) | 3.40 (1.50 to 4.90) | 0.2477 |
| IL-2 | 29.10 (29.00 to 29.40) | 28.50 (20.00 to 29.19) | 0.0148*** |
| IL-3 | 45.59 (42.10 to 47.21) | 58.00 (45.97 to 64.00) | 0.0405*** |
| IL-4 | 8.55 (8.50 to 8.75) | 8.15 (7.95 to 8.82) | 0.1923 |
| IL-6 | 4.44 (3.97 to 4.80) | 4.24 (3.75 to 5.96) | 0.9328 |
| IL-10 | 17.27 (17.13 to 17.70) | 17.20 (15.40 to 20.10) | 0.5952 |
| TNF-α | 22.00 (21.05 to 23.95) | 19.17 (17.00 to 22.81) | 0.0025*** |
| IFN-γ | 46.13 (45.80 to 49.72) | 45.00 (43.99 to 51.00) | 0.0824 |
| IFN-α | 47.16 (12.50 to 70.19) | 45.53 (39.05 to 68.48) | 0.4736 |
Data are presented as medians and inter-quartile range;
P value of two-group permutation test; serum cytokine levels were compared using two-group multivariate permutation test, with the overall P value of 0.0095;
statistically significant.
Based on the results of the 2-group multivariate permutation test, serum level of IL-4 in adult ITP patients was higher than in control subjects. No significant differences of other cytokine levels were observed (Table 3).
Table 3.
Serum cytokine levels in adults with newly diagnosed ITP and in healthy controls.
| Cytokine (pg/mL) | Healthy adults* | Adults with ITP* | P value** |
|---|---|---|---|
| IL-1α | 2.60 (2.05 to 3.13) | 3.10 (2.70 to 3.80) | 0.0720 |
| IL-2 | 26.00 (25.50 to 27.40) | 27.50 (21.00 to 29.00) | 0.2982 |
| IL-3 | 64.25 (57.21 to 75.00) | 60.00 (32.40 to 69.90) | 0.2212 |
| IL-4 | 9.65 (8.90 to 12.65) | 11.50 (9.10 to 21.00) | 0.0378 |
| IL-6 | 7.64 (6.66 to 8.92) | 8.00 (7.00 to 9.10) | 0.3462 |
| IL-10 | 17.65 (16.55 to 18.95) | 16.60 (14.10 to 17.00) | 0.0130 |
| TNF-α | 19.75 (18.50 to 21.33) | 18.30 (16.60 to 21.00) | 0.0914 |
| IFN-γ | 59.35 (43.06 to 62.40) | 61.30 (43.97 to 68.30) | 0.3718 |
| IFN-α | 20.40 (11.05 to 46.35) | 23.45 (14.50 to 43.00) | 0.7598 |
Data are presented as means and inter-quartile range;
P value of two-group permutation test; the data were compared using two-group multivariate permutation test, with the overall P value of 0.1530.
A comparison of serum cytokine levels at diagnosis in children and adults with ITP is presented in Table 4. Pediatric patients had significantly lower levels of IL-4 (p=0.0003), IL-6 (p=0.0006), and IFN-γ (p=0.0075), and significantly higher level of IFN-α (p=0.0095). There were no significant differences in the serum levels of other cytokines (IL-1α, IL-2, IL-3, IL-10, and TNF-α).
Table 4.
Serum cytokines in children and adults with newly diagnosed ITP.
| Cytokine (pg/mL) | Children with ITP* | Adults with ITP* | P value** |
|---|---|---|---|
| IL-1α | 3.40 (1.50 to 4.90) | 3.10 (2.70 to 3.80) | 0.7839 |
| IL-2 | 28.50 (20.00 to 29.19) | 27.50 (21.00 to 29.00) | 0.5832 |
| IL-3 | 58.00 (45.97 to 64.00) | 60.00 (32.40 to 69.90) | 0.3065 |
| IL-4 | 8.15 (7.95 to 8.82) | 11.50 (9.10 to 21.00) | 0.0003 |
| IL-6 | 4.24 (3.75 to 5.96) | 8.00 (7.00 to 9.10) | 0.0006 |
| IL-10 | 17.20 (15.40 to 20.10) | 16.60 (14.10 to 17.00) | 0.1236 |
| TNF-α | 19.17 (17.00 to 22.81) | 18.30 (16.60 to 21.00) | 0.4046 |
| IFN-α | 45.00 (43.99 to 51.00) | 61.30 (43.97 to 68.30) | 0.0074 |
| IFN-α | 45.53 (39.05 to 68.48) | 23.45 (14.50 to 43.00) | 0.0095 |
Data are presented as means and inter-quartile range;
P value of two-group permutation test; the data were compared using two-group multivariate permutation test, with the overall P value of 0.0283.
Multivariate analysis of cytokine levels in healthy children and children with ITP was done using the JRIP classification system in Weka software, which generates rules that explain differences between groups under investigation. The result of analysis with only 1 rule extracted suggests that the serum level of TNF-α of 21.00 pg/mL is the most informative variable for discrimination between healthy children and children with ITP, with 81.08% of individuals correctly classified. The results of analysis are presented in Table 5 and in Figure 1.
Table 5.
JRIP rule and performace of classifier (confusion matrix) suggest that the serum level of TNF-α is the most informative variable for discrimination between healthy children and the children with ITP.
| JRIP rule | Confusion matrix |
|---|---|
| IF (TNF-α ≥21 pg/mL) THAN Group = control children | a b <-- classified as |
| ELSE Group = children with ITP (42.0/4.0) | 22 4 | a = control children 10 38 | b = children with ITP |
Figure 1.
Serum levels of TNF-α (pg/mL) in healthy children and children with ITP.
Discussion
Immune thrombocytopenia is an autoimmune disease associated with cytokine deregulation. Results from the current study suggest differences in serum levels of some cytokines between newly diagnosed pediatric patients with ITP and healthy controls, and between pediatric and adult ITP patients, associated with differences in platelet count between pediatric and adult newly diagnosed ITP patients.
Our findings reveal a significantly lower platelet count in children than in adults with newly diagnosed ITP. Kühne et al., on behalf of the Intercontinental Cooperative ITP Study Group, studied the data of 1784 children and 340 adults and revealed that children and adults with newly diagnosed immune thrombocytopenia had similarities in presenting platelet counts [18]. Additionally, the levels of 3 different cytokines (decrease in IL-2 and TNF-α increase in IL-3) were different in children with ITP compared to healthy children. However, only 1 cytokine (increase in IL-4) was statistically different in adults with ITP compared to healthy controls. We did not find the differences in IL-10 serum concentrations between children with acute ITP and controls, in contrast to del Vechio, who found significantly higher levels of IL-10 in children with acute ITP. In the same study, serum levels of TNF-α and IL-2 did not differ significantly between patients and controls, but we found lower levels of TNF-α and IL-2 in our study [19]. Moreover, TNF-α was the most informative variable for discrimination between healthy children and children with ITP, with 81.08% of individuals correctly classified. Subsequently, both in our study and in the del Vechio et al. study, the relative levels of INF-γ and IL-6 did not differ significantly between patients and controls.
All of the above results suggest a Th2-like cytokine pattern in patients with ITP.
Additionally, our results show significantly higher levels of IL-4, IL-6, and IFN-γ in adults with ITP as compared to diseased children. This finding is in line with observation that aging may be accompanied by a gradual increase of certain cytokine levels, such as IFN-γ [20].
Conclusions
The finding of significant differences in serum cytokine levels between patients and healthy controls indicates that cytokine disturbances – especially changes in IL-4 – might be involved in the pathogenesis of newly diagnosed ITP in both pediatric and adult patients. Furthermore, TNF-α should be considered as a marker for discrimination between healthy children and those with ITP.
Footnotes
Source of support: This work was supported by grant number 098-0982464-2394 from The Ministry of Science, Education, and Sports, Republic of Croatia
References
- 1.Ferrara M, Bertocco F, Ferrara D, Capozzi L. Chronic immune thrombocytopenic purpura in childhood: pathogenetic mechanisms and management. Hematology. 2012;17:363–66. doi: 10.1179/1607845412Y.0000000011. [DOI] [PubMed] [Google Scholar]
- 2.Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386–93. doi: 10.1182/blood-2008-07-162503. [DOI] [PubMed] [Google Scholar]
- 3.Stiakaki E, Perdikogianni C, Thomou C, et al. Idiopathic thrombocytopenic purpura in childhood: twenty years of experience in a single center. Padiatr Int. 2012;54:524–27. doi: 10.1111/j.1442-200X.2012.03606.x. [DOI] [PubMed] [Google Scholar]
- 4.Michel M, Rauzy OB, Thoraval FR, et al. Characteristics and outcome of immune thrombocytopenia in elderly: results from a single center case-controlled study. Am J Hematol. 2011;86:980–84. doi: 10.1002/ajh.22170. [DOI] [PubMed] [Google Scholar]
- 5.Zhong H, Bao W, Li X, et al. CD16+ monocytes control T-cell subset development in immune thrombocytopenia. Blood. 2012;120:3326–35. doi: 10.1182/blood-2012-06-434605. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Chang DY, Ouyang J, Zhou RF, et al. Profiles of different subsets of CD(4)(+) T cells in chronic idiopathic thrombocytopenic purpura. Zhonghua Nei Ke Za Zhi. 2010;49:213–16. [PubMed] [Google Scholar]
- 7.Saitoh T, Kasamatsu T, Inoue M, et al. Interleukin-10 gene polymorphism reflects the severity of chronic immune thrombocytopenia in Japanese patients. Int J Lab Hematol. 2011;33:526–32. doi: 10.1111/j.1751-553X.2011.01320.x. [DOI] [PubMed] [Google Scholar]
- 8.Pesmatzoglou M, Lourou M, Goulielmos GN, et al. DNA methyltransferase 3B gene promoter and interleukin-1 receptor antagonist polymorphisms in childhood immune thrombocytopenia. Clin Dev Immunol. 2012;2012:352059. doi: 10.1155/2012/352059. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Gu D, Chen Z, Zhao H, et al. Th1 (CXCL10) and Th2 (CCL2) chemokine expression in patients with immune thrombocytopenia. Hum Immunol. 2010;71:586–91. doi: 10.1016/j.humimm.2010.02.010. [DOI] [PubMed] [Google Scholar]
- 10.Guo XH, Zhao F, Shi W, et al. Detection and clinical significance of Th1/Th2 cytokines in patients with idiopathic thrombocytopenic purpura. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012;28:1185–87. [PubMed] [Google Scholar]
- 11.Chen X, Chen S, Li C, et al. Skewed T-cell subsets and enhanced macrophages phagocytosis in the spleen of patients with immune thrombocytopenia failing glucocorticoids. Int J Hematol. 2011;94:248–54. doi: 10.1007/s12185-011-0908-6. [DOI] [PubMed] [Google Scholar]
- 12.Zhang J, Ma D, Zhu X, et al. Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpura. Haematologica. 2009;94:1326–29. doi: 10.3324/haematol.2009.007823. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Jin CQ, Liu F, Dong HX, et al. Type 2 polarized immune response holds a major position in Epstein-Barr virus-related idiopathic thrombocytopenic purpura (EBV-ITP) Int J Lab Hematol. 2012;34:164–71. doi: 10.1111/j.1751-553X.2011.01375.x. [DOI] [PubMed] [Google Scholar]
- 14.http://www.rndsystems.com/product_detail_objectname_elisa_assay_product.aspx
- 15.Witten IH, Frank E, Hall MA. Data mining: practical machine learning tools and techniques. third ed. Amsterdam: Morgan Kaufmann; 2011. [Google Scholar]
- 16.R Development Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2011. http://www.R-project.org. [Google Scholar]
- 17.Motulsky H. Intuitive biostatistics. Oxford: Oxford University Press; 1995. [Google Scholar]
- 18.Kühne T, Berchtold W, Michaels LA, et al. Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group. Haematologica. 2011;96:1831–37. doi: 10.3324/haematol.2011.050799. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Del Vecchio GC, Giordano P, Tesse R, et al. Clinical significance of serum cytokine levels and thrombopoietic markers in childhood idiopathic thrombocytopenic purpura. Blood Transfus. 2012;10:194–99. doi: 10.2450/2011.0055-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Čulić S, Labar B, Marušić A, Salamunić I. Correlations among age, cytokines, lymphocyte subtypes, and platelet counts in autoimmune thrombocytopenic purpura. Pediatr Blood Cancer. 2006;47:671–74. doi: 10.1002/pbc.20999. [DOI] [PubMed] [Google Scholar]

